Wearable Oxygen Monitoring Devices Patent Landscape Analysis Report 2026 Edition

Wearable Oxygen Monitoring Devices Market Size, Growth Trends, and Industry Outlook

Wearable oxygen monitoring devices track peripheral oxygen saturation and pulse rate continuously from the wrist, finger, ear, ring or an adhesive chest patch. Clinicians use the readings to spot nocturnal desaturation, early deterioration after discharge and exertional hypoxaemia in chronic lung disease. Consumer demand adds scale, as smartwatch and smart ring buyers treat overnight oxygen trends as a routine wellness metric. Cleared medical devices and consumer products now share the same reflectance optical building blocks.

The market growth is driven by sleep apnoea screening, home management of chronic lung disease and the arrival of cleared pulse oximetry in consumer wearables. Obstructive sleep apnoea affects an estimated 936 million adults, and many first notice it through an overnight oxygen trend.

The FDA draft guidance of January 2025 asks for clinical testing across skin tones, which raises development cost for new entrants and favours makers with large validation datasets. Apple restored Blood Oxygen in the United States on 14 August 2025 by moving the calculation to the paired iPhone, which returned a very large installed base to oxygen tracking. Danaher's February 2026 agreement to acquire Masimo for about USD 9.9 billion in cash shows the strategic value attached to oximetry intellectual property.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Wearable Oxygen Monitoring Devices Patent Filing Trends and Innovation Activity

Patent filings for wearable oxygen monitoring devices concentrate on reflectance optical modules, signal conditioning and form-factor engineering. Applicants file first in the United States, China and South Korea, then extend through the Patent Cooperation Treaty to Europe and Japan. Smartwatch and smart ring makers have widened the applicant base beyond oximetry specialists, which lifted the share of consumer electronics claims.

The dataset holds roughly 5,870 patent families, with filings peaking between 2021 and 2023 as home oximetry demand and ring launches drove new applications. Grants in 2025 reached about 340, and the United States accounts for around 2,310 patents. Continuation practice at leading oximetry specialists keeps related grants arriving every year.

Rising demand for overnight and ambulatory oxygen tracking has pushed applicants to protect sensor placement, wavelength selection and motion-tolerant algorithms across several form factors.

Scope of the Wearable Oxygen Monitoring Devices Patent Landscape Analysis Report

The report covers patents on wearable devices that measure blood oxygen saturation non-invasively, including wrist-worn watches and bands, smart rings, finger and ear-clip sensors, adhesive patches and smart garments. Coverage extends to the optical front end, analogue signal chain, firmware algorithms, companion software and clinical alerting workflows.

Granted patents and published applications from 2005 to 2026 are mapped by assignee, jurisdiction, technology and clinical use. Bedside and bench-top oximeters enter the analysis when a claim covers a body-worn or ambulatory implementation.

Entities profiled include medical technology manufacturers, consumer electronics groups, smart ring start-ups, universities and research institutes, and contract sensor module suppliers.

Global Wearable Oxygen Monitoring Devices Patent Landscape Analysis

Wearable Oxygen Monitoring Devices Patent Filing Trend Analysis

Annual filings grew at an estimated 9% between 2020 and 2024, led by reflectance sensor design and algorithms that correct for motion and skin tone. Smart ring and adhesive patch claims grew faster, at an estimated 14% a year, as makers shrank optical modules to fit smaller housings.

Regulatory attention to accuracy across skin tones, sharpened by the FDA draft guidance of January 2025, raised the number of filings on multi-wavelength calibration and perfusion-index compensation. Machine learning claims on hypoxaemia prediction and apnoea event detection now appear in a rising share of new families.

Leading Companies and Assignee Analysis in the Wearable Oxygen Monitoring Devices Patent Landscape

Geographic Analysis of Wearable Oxygen Monitoring Devices Patent Activity

The report assesses patent activity across major jurisdictions, including:

• United States
• Europe
• China
• Japan
• South Korea
• India
• International and WIPO filings

The United States leads filing volume, supported by the Masimo and Apple portfolios and active litigation that keeps claims under scrutiny. China ranks second as Huawei, Xiaomi and local sensor makers file on ring and watch optics. Europe ranks third, with Philips and university groups filing on clinical use cases, and South Korea and Japan follow.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Wearable Oxygen Monitoring Devices Technology Segmentation and Innovation Areas

The report segments technology activity into the following areas:

• Reflectance optical sensor modules
• Motion artefact suppression
• Low-perfusion and skin-tone compensation
• Ring and patch miniaturisation
• Cloud analytics and hypoxaemia alerting

Among these, reflectance optical sensor modules hold the largest share of families, followed by motion artefact suppression.

Competitive Landscape and Emerging Trends in the Wearable Oxygen Monitoring Devices Market

Competition spans oximetry specialists, consumer electronics groups and monitoring platform companies. Masimo holds the deepest oximetry-specific portfolio, covering signal extraction and watch-based claims. Apple and Samsung Electronics file extensively on sensor placement in watch housings, and Philips and Google add clinical workflow and health platform claims. Litigation between Masimo and Apple ties portfolio strength directly to product availability.

Companies are focusing on:

• Reflectance sensor geometry and LED photodiode placement
• Motion and ambient light rejection
• Skin-tone and perfusion compensation
• Smart ring and adhesive patch form factors
• Overnight desaturation and apnoea event detection
• Companion software and clinical alert pathways
• Battery-efficient sampling schedules

Emerging innovation themes include multi-wavelength calibration for darker skin tones, ring-based clinical-grade oximetry, on-device machine learning for apnoea event detection and smart garment sensors. Cuffless blood pressure and hydration estimation are being combined with oxygen sensing on a single optical engine. Claims for ear-worn oximetry are also rising in hearable portfolios.

Strategic Insights from the Wearable Oxygen Monitoring Devices Patent Landscape

Strategic activity centres on securing optical sensing claims and defending them. The Masimo and Apple dispute produced a USD 634 million jury verdict in November 2025, and in April 2026 the US International Trade Commission declined to review a ruling that cleared Apple's redesigned feature. Oura won exclusion orders against Ultrahuman and RingConn in 2025, and RingConn then took a licence. Licensing and enforcement therefore shape entry for smaller ring makers.

Technology segments, assignee positions and jurisdictional trends are organised so that the report provides actionable intelligence supporting:

• Intellectual property strategy
• R&D prioritisation
• Competitive benchmarking
• Technology scouting
• Licensing evaluation
• Partnership assessment
• Investment analysis
• Market entry planning
• Portfolio expansion strategy

Research Methodology for the Wearable Oxygen Monitoring Devices Patent Landscape Analysis

The patent search covered the United States Patent and Trademark Office, the European Patent Office, the World Intellectual Property Organization, the China National Intellectual Property Administration, the Korean Intellectual Property Office and the Japan Patent Office. Records from 2005 to 2026 were drawn from DOCDB and national full-text sources.

Queries combined CPC classes A61B 5/1455 (optical oximetry), A61B 5/6801 (wearable sensors), A61B 5/7203 (noise and artefact processing) and G16H 40/63 with keywords for photoplethysmography, SpO2, ring, patch and watch. Records were screened for claim relevance and consolidated into patent families, with legal status checked for each member.

The market side draws on FDA 510(k) and CE clearance records, company filings, ClinicalTrials.gov registrations and peer-reviewed literature on oximetry accuracy. Assignee names were normalised across subsidiaries, and segment shares were estimated from classified family counts.

Related Reports

Pulse Oximeter Market

Digital Patient Monitoring Devices Patent Landscape

IoMT Wearable Devices Patent Landscape